Clinical Trial Update: Trial of NanoPac Focal Therapy for Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of NanoPac focal therapy for prostate cancer was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Neoplasms Male
• Localized Cancer
• Prostate Adenocarcinoma
• Prostate Cancer
• Prostatic Neoplasm
• Urogenital Neoplasms

Drugs mentioned

• NanoPac (paclitaxel nanoparticle formulation)

Snippet

Sponsor: NanOlogy, LLC | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2022-03-29